Associazione Oncologia Traslazionale

Quick facts

Phase 2 pipeline

• Cancer Stem Cells Sensitivity Assay · Oncology
  This drug targets cancer stem cells to inhibit tumor growth.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Associazione Oncologia Traslazionale portfolio CI brief
• Associazione Oncologia Traslazionale pipeline updates RSS

Related

• Sector hub: All tracked pharma companies